Prodotti GS / Area HIV
Giugno 2021: Variazioni RCP Prodotti HIV
|
Product |
Submission description |
RCP availability |
|
Atripla |
Type IB variation to update bone effects information |
Giugno 2021 |
|
Emtriva |
|
|
|
Viread |
|
|
|
Stribild |
Type II variation to submit DDI with cutaneous corticosteroids
|
Fine Ottobre 2021 |
|
Truvada |
|
|
|
Eviplera |
|
|
|
Genvoya |
Type II Variation to add long-term safety and efficacy data (Week 48) from GS-US-292-0106 for existing Cohort 2 for patients weighing ≥ 25 kg to < 35 kg and aged 6 to < 12 years of age. |
Fine Agosto 2021 |
|
Type II variation to submit DDI with cutaneous corticosteroids
|
Fine Ottobre 2021 |
|
|
Descovy |
|
|
|
Odefsey |
|
|
|
Biktarvy |
|
|
|
Newsletter Giugno 2021 |
||
Grazie per il tuo feedback!